BEAM
Price
$27.37
Change
-$0.14 (-0.51%)
Updated
Dec 12, 04:59 PM (EDT)
Capitalization
2.79B
81 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$11.08
Change
+$0.27 (+2.50%)
Updated
Dec 12, 03:47 PM (EDT)
Capitalization
413.15M
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs TRDA

Header iconBEAM vs TRDA Comparison
Open Charts BEAM vs TRDABanner chart's image
Beam Therapeutics
Price$27.37
Change-$0.14 (-0.51%)
Volume$57.44K
Capitalization2.79B
Entrada Therapeutics
Price$11.08
Change+$0.27 (+2.50%)
Volume$200
Capitalization413.15M
BEAM vs TRDA Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. TRDA commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (BEAM: $27.51 vs. TRDA: $10.81)
Brand notoriety: BEAM and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 60% vs. TRDA: 90%
Market capitalization -- BEAM: $2.79B vs. TRDA: $413.15M
BEAM [@Biotechnology] is valued at $2.79B. TRDA’s [@Biotechnology] market capitalization is $413.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • TRDA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than TRDA.

Price Growth

BEAM (@Biotechnology) experienced а -4.84% price change this week, while TRDA (@Biotechnology) price change was +6.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

TRDA is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.79B) has a higher market cap than TRDA($413M). BEAM YTD gains are higher at: 10.927 vs. TRDA (-37.478). TRDA has higher annual earnings (EBITDA): -92.26M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. TRDA (354M). TRDA has less debt than BEAM: TRDA (54.7M) vs BEAM (155M). TRDA has higher revenues than BEAM: TRDA (79.5M) vs BEAM (60.3M).
BEAMTRDABEAM / TRDA
Capitalization2.79B413M676%
EBITDA-414.33M-92.26M449%
Gain YTD10.927-37.478-29%
P/E RatioN/A10.26-
Revenue60.3M79.5M76%
Total Cash1.15B354M325%
Total Debt155M54.7M283%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMTRDA
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 23 days ago
84%
Bearish Trend 26 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WVMRX12.260.12
+0.99%
William Blair Mid Cap Value R6
NELAX64.940.13
+0.20%
Nuveen Equity Long/Short A
REAIX26.280.02
+0.08%
American Century Real Estate I
TMPIX58.58-0.52
-0.88%
Touchstone Mid Cap Institutional
JDSCX34.26-1.00
-2.84%
JPMorgan Small Cap Blend I